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Abstract
Francisella tularensis subsp. tularensis (type A) is subdivided into clades A1 and A2. Human tularemia infections caused by A1 and A2
differ with respect to clinical outcome; A1 infections are associated with a higher case fatality rate. In this study, we develop and evaluate
TaqMan polymerase chain reaction (PCR) assays for identification of A1 and A2. Both assays were shown to be specific to either A1 or A2,
with sensitivities of 10 genomic equivalents. Real-time PCR results for identification of A1 and A2 were in complete agreement with results
obtained by pulsed field gel electrophoresis analysis or conventional PCR when specimens from sporadic tularemia cases and a tularemia
outbreak involving both A1 and A2 were tested. In addition, outbreak samples not previously typed to the clade level could be classified as
A1 or A2. The assays described here provide new diagnostic tools with a level of sensitivity not previously available for identification of A1
and A2 infections.
Published by Elsevier Inc.
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1. Introduction
Francisella tularensis is a Gram-negative bacterial
pathogen that causes the zoonotic disease tularemia (Ellis
et al., 2002). Two subspecies, F. tularensis subsp. tularensis
(type A) and F. tularensis subsp. holarctica (type B), are of
clinical relevance, and both can cause several distinct
presentations of tularemia. Tularemia infections caused by
F. tularensis subsp. tularensis are documented only in
North America, whereas F. tularensis subsp. holarctica
causes infections in North America, Europe, and Asia (Ellis
et al., 2002; Sjostedt, 2005). In the United States, an
average of 124 human cases of tularemia is reported each
year (Centers for Disease Control and Prevention [CDC],
2002). F. tularensis subsp. tularensis has traditionally been
considered more virulent than F. tularensis subsp. holarc-
tica based on mean lethal dose studies in rabbits (Ellis et al.,
2002). Infections caused by F. tularensis subsp tularensis
are acquired by arthropod bites (ticks and deer-flies),
handling of infected animal carcasses, and inhalation of
infective aerosols. Outbreaks involving F. tularensis subsp.
tularensis are rare. On Martha's Vineyard, cases caused by
this subspecies have been reported between 2000 and 2006,
with only two recognized outbreaks occurring in the last 22
years (1978 and 2000) (Feldman et al., 2001, 2003; Matyas
et al., 2007).
Historically, F. tularensis subsp. tularensis strains have
been considered equivalent with respect to virulence.
Molecular methods, specifically multiple locus variable
number tandem repeat analysis (MLVA), pulsed field gel
electrophoresis (PFGE), and genome sequence comparisons,
have separated this subspecies into 2 genetically distinct
clades, A1 (also known as A.I and A-east) and A2 (also
known as A.II and A-west) (Beckstrom-Sternberg et al.,
2007; Farlow et al., 2005; Johansson et al., 2004; Larsson et
al., 2007; Molins-Schneekloth et al., 2008; Nubel et al.,
2006; Staples et al., 2006; Svensson et al., 2005). Recently, a
difference in the severity of human illness caused by F.
tularensis subsp. tularensis A1 and A2 has been reported
(Staples et al., 2006). A1 isolates were recovered more
frequently from the lung and blood as compared with A2
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isolates. In addition, case fatality rates were shown to differ
significantly between infections caused by A1 and A2, at
14% and 0%, respectively. Despite this difference in clinical
severity, the only methods currently available for differ-
entiating F. tularensis subsp. tularensis clades A1 and A2
require a recovered isolate (PFGE and MLVA) or are lacking
in sensitivity (conventional polymerase chain reaction [PCR]
and MLVA) (Farlow et al., 2005; Molins-Schneekloth et al.,
2008; Staples et al., 2006).
Here, we develop and evaluate TaqMan PCR assays for
the identification of F. tularensis subsp. tularensis clades A1
and A2. Two regions of difference (RD), RD-5 and RD-3,
previously identified by suppression subtractive hybridiza-
tion, were used for assay development (Molins-Schneekloth
et al., 2008). RD-5 lies within a region spanning both gene-
encoding regions (hypothetical protein and a pseudogene for
methyltransferase) and an intergenic region. It is present in
A2 strains and absent from A1 strains. RD-3 lies within a
hypothetical protein and is present in A1 strains and absent
from A2 strains. The A1 and A2 TaqMan assays demon-
strated good sensitivity and specificity. Using samples from
sporadic tularemia cases and a 2007 deer-fly–associated
tularemia outbreak in Utah in which both A1 and A2 caused
disease (Petersen et al., 2008), we show the use of these
assays for identification of A1 and A2. This study provides
new tools that enhance our ability to investigate F. tularensis
subsp. tularensis outbreaks as well as offers clinical
laboratories and researchers a rapid method for identification
of F. tularensis subsp. tularensis A1 and A2.
2. Materials and methods
2.1. Bacterial isolates and DNA preparation
Representative strains of F. tularensis, Francisella
novicida, and Francisella philomiragia were grown from
frozen stocks on cysteine heart agar with 9% chocolatized
sheep blood (CHAB) at 35 °C for 48 h, followed by
subculture onto CHAB for 24 h at 35 °C. Other bacterial
strains were grown as previously described (Versage et al.,
2003). Genomic DNAwas isolated using the QIAamp DNA
mini kit (Qiagen, Valencia, CA) according to the manufac-
turer's instructions or as previously described (Kugeler et al.,
2006; Versage et al., 2003). Double-stranded DNA concen-
tration was determined using PicoGreen and a NanoDrop
Fluorospectrometer (Thermo Fisher Scientific, Waltham,
MA). Aliquots of purified DNA were stored at −20 °C.
Previously frozen DNA was verified amplifiable using the
16S rRNA gene.
2.2. Outbreak specimens
A total of 20 outbreak-associated specimens from human
cases (n = 11) and desiccated rabbit carcasses (n = 8) were
tested. Twelve samples were collected from 11 human
tularemia cases; 5 culture-confirmed cases (5 F. tularensis
isolates) (Petersen et al., 2008), and 6 culture-negative, PCR-
positive cases (n=7; 5 wound swabs, 2 lymph node aspirates).
The lymph node aspirates were drawn 3 weeks apart from the
same patient. Eight bone marrow samples were collected
from the rabbit carcasses. DNA was isolated from all 20
specimens as described above (culture-positive samples) or
as previously described (Petersen et al., 2008) and tested by
real-time PCR using the F. tularensis multitarget assay and
the F. tularensis subsp. tularensis assay (Kugeler et al., 2006;
Versage et al., 2003). Culture-positive specimens were
previously identified as either A1 or A2 by PmeI PFGE
typing (Petersen et al., 2008). Five culture-negative, PCR-
positive specimens were previously identified as either A1 or
A2 by conventional PCR (Petersen et al., 2008).
2.3. TaqMan primers and probes
Primers and probes were designed using ABI Primer
Express Software v2.0 (Applied Biosystems, Foster City,
CA) and synthesized by the CDC Biotechnology Core
Facility (Atlanta, GA). Before synthesis, BLAST (blastn)
analyses were performed to confirm specificity. The primers
for the A1 assay were RD5RT-F (5′-CACTATCTTTACTT-
TAGCTTTGCCACAA-3′) and RD5RT-R-2 (5′-TGAT-
CCTTGGCATAAGAAAAAACA-3′) and probe RD5RT-P
(5 ′ -CTGGACAAAAA″T″ATTATCAAAGATTAA-
CAAGCCTACGC-3′). For the A2-specific assay, primers
were RD3RT-F (5′-GACAATCATTTAAGCAAAA-
CGCTACT-3′) and RD3RT-R (3′- GCAGGTAATG-
TAGTTTTAGCAAATGC-5′) and probe RD3RT-P
(5′-TTCTAGGATAAqTqCATCTGCGATACCGTTGCC-3′).
Probes were synthesized with an internal Black Hole
Quencher I (bhq1-dT) at the position “T” and a 6-
carboxyfluorescein reporter at the 5′ end.
2.4. PCR conditions
PCR conditions were optimized using 1 ng of DNA from
F. tularensis subsp. tularensis strains MA00-2987 (A1) and
WY96-3418 (A2). A total volume of 20 μL was used for
every PCR reaction. All reactions contained final concentra-
tions of 1× LightCycler Fast Start DNA master hybridization
probe mix (Roche Applied Sciences, Indianapolis, IN),
5 mmol/L MgCl2, 0.75 μmol/L of each A1 primer or 0.5
μmol/L of each A2 primer, 0.5 U of uracil-DNA glycosylase
(Roche), and 0.2 μmol/L probe. For outbreak specimens, the
volume of sample tested ranged from 1 to 10 μL. Thermal
cycling conditions were as follows: 1 cycle of 50 °C for
2 min, 1 cycle of 95 °C for 10 min, 45 cycles of 95 °C for 10
s, and 60 °C for 30 s, followed by 1 cycle of 45 °C for 5 min.
PCR amplification and detection were performed using the
LightCycler 1.2 (Roche Applied Sciences). For each PCR
run, a negative control (no DNA) and a positive control (1 ng
of DNA from either strain MA00-2987 or WY96-3418) were
included. Ct values were determined by performing
automatic quantification using the 2nd derivative maximum
method with the y axis set to F1/F3 (LightCycler software
version 3.5).
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2.5. Specificity and sensitivity determinants
Specificity testing was performed using 1 ng of DNA
from F. tularensis subsp. tularensis clade A1 or A2, F.
tularensis subsp. holarctica, F. novicida, F. philomiragia, or
other bacterial species. All 46 F. tularensis subsp. tularensis
strains were typed by PmeI PFGE as A1 or A2 using the
previously described method (Staples et al., 2006). Genome
equivalents (GEs) were calculated based on genome sizes of
1 892 819 and 1 898 476 bp for F. tularensis subsp. tular-
ensis clade A1 strain SCHU S4 and F. tularensis subsp. tu-
larensis clade A2 strain WY96-3418, respectively. One GE
Table 1
Evaluation of specificity using F. tularensis subsp. tularensis A1 and A2 isolates from sporadic and outbreak-associated tularemia cases
F. tularensis subsp. tularensisa CDC accession no. Source Yearb Geographic origin A1 assay (Ct value)
c A2 assay (Ct value)
c
Clade A1 MA00-2987 Human 2000 Massachusetts 20.87 ­
AR99-3448 Human 1999 Arkansas 20.57 ­
MO02-1911 Human 2002 Missouri 21.15 ­
NE03-1457 Human 2003 Nebraska 21.14 ­
NY04-2565 Human 2004 New York 21.06 ­
OK01-2528 Human 2001 Oklahoma 21.12 ­
SCHU S4 Human 1940s Ohio 20.49 ­
SD00-3147 Human 2000 South Dakota 20.62 ­
VA00-1000 Human 2000 Virginia 20.52 ­
ND00-0952 Human 2000 North Dakota 20.62 ­
KS00-0948 Cat 2000 Kansas 20.92 ­
NC99-3990 Rabbit 1999 North Carolina 21.00 ­
AR00-0028 Human 2000 Arkansas 20.73 ­
NC97-3057 Rabbit 1997 North Carolina 20.35 ­
MO01-1907 Human 2001 Missouri 20.86 ­
OK00-2731 Human 2000 Oklahoma 20.75 ­
UT98-3134 Human 1998 Utah 21.27 ­
NC01-5379 Cat 2001 North Carolina 20.93 ­
AR98-2146 Rabbit 1998 Arkansas 21.17 ­
OK00-4337 Human 2000 Oklahoma 20.72 ­
AR01-1117 Human 2001 Arkansas 21.13 ­
GA02-5501 Human 1982 Louisiana 21.22 ­
IL01-3022 Human 2001 Illinois 20.88 ­
NY04-2787 Rabbit 2004 New York 21.28 ­
UT07-4262 Human 2007 Utah 21.21 ­
UT07-4263 Human 2007 Utah 21.19 ­
UT07-4265 Human 2007 Utah 20.44 ­
Clade A2 WY96-3418 Human 1996 Wyoming – 18.72
AZ01-4999 Human 2001 Arizona – 19.50
CA02-0099 Human 2002 California – 18.28
GA02-5453 Human 1993 Wyoming ­ 18.94
IDO4-2687 Human 2004 Oregon ­ 19.44
UT02-1927 Human 2002 Utah ­ 19.28
WY01-3847 Human 2001 Wyoming ­ 18.97
WY01-3911 Human 2001 Wyoming ­ 19.80
WY03-1228 Human 2003 Wyoming ­ 20.15
NM99-0295 Rabbit 1999 New Mexico ­ 20.03
CO01-2364 Cat 2001 Colorado ­ 19.02
CO01-3713 Rabbit 2001 Colorado ­ 19.61
CO04-2154 Rabbit 2004 Colorado ­ 19.27
OR02-0978 Cat 2002 Oregon ­ 19.40
UT01-2936 Human 2001 Utah ­ 19.50
NV87-3695 Human 1987 Nevada ­ 19.59
NM99-1823 Human 1999 New Mexico ­ 20.03
WY01-3650 Human 2001 Wyoming ­ 19.72
OR00-3117 Human 2000 Oregon ­ 19.58
CO81-0728 Human 1981 Colorado ­ 19.63
AZ87-2825 Human 1987 Arizona ­ 19.47
CO02-1841 Cat 2002 Colorado ­ 19.65
UT07-4632 Human 2007 Utah ­ 19.68
UT07-4633 Human 2007 Utah ­ 19.95
a Clade information was known for all isolates by PmeI PFGE genotyping.
b Isolates (not outbreak associated or a reference strain) were obtained from sporadic tularemia cases occurring for a 26-year period.
c A negative Ct value (−) represents no logarithmic amplification detected within 41 amplification cycles.
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of either A1 or A2 was estimated at approximately 2 fg of
DNA. Tenfold serial dilutions of DNA ranging from 1 to
100 000 GEs were prepared in nuclease-free water and tested
in duplicate for each assay. Standard curves were generated
using the LightCycler software version 3.5.
2.6. Inhibition testing
A1 (SCHU S4) or A2 (WY96-3418) DNAwas diluted to
1000 GEs, 100 GEs, and 10 GEs and mixed with DNA from
the opposing F. tularensis subsp. tularensis clade at ratios of
1:0, 1:1, 1:2, 1:5, and 1:10. All mixtures of A1 and A2 were
tested in duplicate.
3. Results
3.1. Development and optimization
The A1- and A2-specific assays were targeted against
RD-5 and RD-3, respectively. The A1-specific assay targeted
RD-5, which is present in A2 and absent from A1. The A2-
specific targeted RD-3, which is present in A1 and absent
from A2. These 2 RDs were chosen for development of
TaqMan PCR assays because they showed the most
nucleotide variability within the regions flanking the RD.
In both cases, the TaqMan probe was designed to hybridize
to the junction because this region discriminates A1 from
A2. The amplification size for the A1 and A2 PCR products
is 101 and 111 bp, respectively.
Both assays were optimized for primer concentration,
MgCl2 concentration, and annealing temperature (data not
shown). The optimal concentration of each primer was
determined to be 0.75 μmol/L for the A1-specific assay and
0.5 μmol/L for the A2-specific assay. A final MgCl2
concentration of 5 mmol/L was found to give the best
results for both assays. An annealing temperature of 60 °C
was optimal for performing both assays simultaneously (data
not shown).
3.2. Specificity and sensitivity
Specificity of the 2 TaqMan assays was evaluated using
DNA from 24 F. tularensis subsp. tularensis A1 and 22
F. tularensis subsp. tularensis A2 isolates obtained from
sporadic tularemia cases occurring in different geographic
locations for a 26-year period (Table 1). The A1-specific
assay identified all 24 A1 strains with no cross-reactivity to
A2 strains. Conversely, the A2-specific assay recognized all
22 A2 strains with no cross-reactivity to A1 strains. In
addition, identification of the strains as A1 or A2 by real-
time PCR was in complete agreement with PmeI PFGE
genotyping, validating the ability of these assays to
accurately differentiate A1 and A2 (Table 1). The Ct value
for 1 ng of DNA ranged from 20.35 to 21.28 and from 18.28
to 20.15 for the A1 and A2 assays, respectively (Table 1).
A panel of 20 F. tularensis subsp. holarctica strains, 7
F. novicida strains, 10 F. philomiragia strains (Table 2), and
13 other bacterial species (20 strains total) were also tested for
cross-reactivity with the A1 and A2 assays. The other
bacterial species included Klebsiella oxytoca, Pseudomonas
aeruginosa, Moraxella spp., Haemophilus influenzae, En-
terococcus cloacae, Escherichia coli, Acinetobacter spp.,
Proteus spp., Serratia spp., Streptococcus faecalis, Legio-
nella spp., Yersinia pestis, and Yersinia enterocolitica. No
cross-reactivity was detected with any of the Francisella (F.
tularensis subsp. holarctica,F. novicida, andF. philomiragia)
(Table 2) or other bacterial species tested (data not shown).
Sensitivity testing indicated that both assays reproducibly
detected 10 GEs of F. tularensis DNA. The average Ct value
for the A1 assay for 100 000, 10 000, 1000, 100, and 10 GEs
was 23.92, 27.94, 30.97, 34.75, and 38.12, respectively. The
average Ct value for the A2 assay for 100 000, 10 000, 1000,
100, and 10 GEs was 21.52, 25.13, 28.84, 32.26, and 35.71,
respectively. For both assays, the Ct value for 1 GE was
N41.00. Both TaqMan assays showed good linear log
correlation with a regression coefficient of 1.00 and a
slope of −3.587 for the A1-specific assay and −3.551 for the
A2-specific assay (data not shown).
3.3. Competitive inhibition
The sensitivity of the A1-specific assay in the presence
of A2 DNA and the A2-specific assay in the presence of
A1 DNA was tested because degenerate primer binding
sites for the respective assays are present in both A1 and
A2. The A1-specific assay showed no inhibition in the
presence of 5-fold excess A2 DNA; a sensitivity of 10 GEs
(average Ct value of 38.15) was maintained under these
conditions. When A2 DNA was added at 10 times the
concentration of A1 DNA, a slight inhibitory effect was
noted; the A1-specific assay displayed a sensitivity of 100
GEs, with an average Ct value of 34.59. The A2-specific
assay showed no signs of inhibition in the presence of 10
times excess A1 DNA; a sensitivity of 10 GEs (average Ct
value of 35.46) was maintained under these conditions.
Thus, the real-time assays provide identification of A1 and
A2 in the presence of 10-fold excess DNA of the opposing
clade, demonstrating the ability of these assays to detect
potential A1/A2 coinfections.
3.4. Evaluation and application using outbreak specimens
To evaluate the ability of the TaqMan assays to identify
F. tularensis subsp. tularensis A1 or A2 infections, we
tested DNA extracted from samples collected during a deer-
fly–associated tularemia outbreak in Utah in 2007. Results
for the 5 culture-confirmed human cases obtained with the
A1 and A2 TaqMan assays matched those obtained by
PmeI PFGE (Table 3). Two isolates were identified as A2
(UT07-4632 and UT07-4633), and 3 isolates were identi-
fied as A1 (UT07-4262, UT07-4263, and UT07-4265).
Similarly, when 5 bone marrow DNA samples, extracted
from rabbit carcasses (UT07-5152, UT07-5156, UT07-
5157, UT07-5159, and UT07-5161) collected at the
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outbreak site, were tested with the A1 and A2 real-time
assays, the results matched those obtained using conven-
tional PCR (Table 3). Thus, the A1 and A2 real-time PCR
assays provide results in complete agreement with 2
independent methods, PFGE and conventional PCR,
demonstrating the ability of these assays to accurately
Table 3
Comparison of results for PmeI PFGE typing and conventional PCR versus A1 and A2 TaqMan assays using outbreak samples
Sample
(CDC accession no.)
Source Sample type PmeI
PFGEa
Conventional
PCR
A1 TaqMan assay
(Ct value)
b
A2 TaqMan assay
(Ct value)
b
Clade identified
by A1/A2
TaqMan assay
UT07-4632 Human Isolate A2 NTc ­ 19.68 A2
UT07-4633 Human Isolate A2 NT ­ 19.95 A2
UT07-4262 Human Isolate A1 NT 21.21 ­ A1
UT07-4263 Human Isolate A1 NT 21.19 ­ A1
UT07-4265 Human Isolate A1 NT 20.44 ­ A1
UT07-5152 Rabbit Bone marrow NT A1 23.43 ­ A1
UT07-5156 Rabbit Bone marrow NT A1 26.83 ­ A1
UT07-5157 Rabbit Bone marrow NT A1 18.40 ­ A1
UT07-5159 Rabbit Bone marrow NT A1 19.58 ­ A1
UT07-5161 Rabbit Bone marrow NT A2 ­ 21.45 A2
a Data from previously published study (Petersen et al., 2008).
b A negative Ct value (−) represents no logarithmic amplification detected within 41 amplification cycles.
c NT represents assays that were not tested.
Table 2
Evaluation of specificity using other Francisella strains
Francisella spp. CDC accession no. Source Geographic origin A1 assay (Ct value)
a A2 assay (Ct value)
a
F. tularensis subsp. holarctica LVS Rat Russia ­ ­
KY99-3387 Human Kentucky ­ ­
AZ00-1324 Squirrel Arizona ­ ­
IL00-3633 Human Illinois ­ ­
CN98-5979 Human Canada ­ ­
MO01-1673 Human Missouri ­ ­
OH01-3029 Prairie dog Ohio ­ ­
KY00-1708 Human Kentucky ­ ­
IN98-3055 Rat Indiana ­ ­
UT00-2098 Human Missouri ­ ­
SP98-6120 Rabbit Spain ­ ­
CO96-1243 Vole Colorado ­ ­
CA99-0837 Human California ­ ­
IN00-2758 Human Indiana ­ ­
NM00-2642 Human New Mexico ­ ­
SP98-2108 Human Spain ­ ­
CA99-3992 Monkey California ­ ­
AZ00-1325 Rat Arizona ­ ­
JAP5-3-11 Human Japan ­ ­
KO97-1026 Human Korea ­ ­
F. novicida GA99-3548 Human Louisiana ­ ­
GA99-3549 Human California ­ ­
GA99-3550 Water Utah ­ ­
UT01-4992 Human Utah ­ ­
AS02-0814 Human Australia ­ ­
FX1 Human Texas ­ ­
FX2 Human Texas ­ ­
F. philomiragia GA01-2796 Human California ­ ­
GA01-2799 Human Connecticut ­ ­
GA01-2800 Human Connecticut ­ ­
GA01-2801 Human New York ­ ­
GA01-2802 Human California ­ ­
GA01-2803 Human New Mexico ­ ­
GA01-2804 Human Virginia ­ ­
GA01-2806 Human Massachusetts ­ ­
GA01-2807 Human Unknown ­ ­
GA01-2811 Water Utah ­ ­
a A negative Ct value (−) represents no logarithmic amplification detected within 41 amplification cycles.
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identify A1 and A2 infections by a rapid non–labor-
intensive method (Table 3).
To determine if the A1 and A2 real-time assays could be
used for identification of A1 and A2 infections in culture-
negative, F. tularensis subsp. tularensis PCR-positive
samples, we tested DNA from 6 human cases and 3 rabbit
carcasses (Table 4). Conventional PCR was not previously
able to identify A1 or A2 infections in these specimens
because of limits in sensitivity (Petersen et al., 2008). In
contrast, the A1 and A2 real-time assays were able to identify
infections as either A1 or A2 for all 6 human cases; 3 were
positive for A1 (UT07-6575, UT07-6578, and UT07-6579)
and 3 were positive for A2 (UT07-6576, UT07-6577, UT07-
6580) (Table 4). In addition, 2 independent samples drawn 3
weeks apart from the same patient (UT07-6580 and UT07-
6581) were both positive for A2. The A1 and A2 real-time
assays also identified the infecting type A clade in rabbit
carcasses; 1 was positive for A1 (UT07-5153) and 2 were
positive for A2 (UT07-5158 and UT07-5163). Thus, the
real-time assays were able to identify either A1 or A2 as the
source of infection in primary samples, even in the absence
of a culture.
To look for evidence of A1/A2 coinfection in the outbreak
samples, 10 μL of purified DNA was tested from the 7
human and 8 rabbit culture-negative, PCR-positive speci-
mens using A1 and A2 real-time assays. No evidence of
coinfection was found; all specimens tested positive (Ct
values ranged from 19.23 to 37.66) for either F. tularensis
subsp. tularensis clade A1 or F. tularensis subsp. tularensis
clade A2 under these conditions.
4. Discussion
In this study, we developed 2 real-time TaqMan PCR
assays for rapid identification of F. tularensis subsp. tular-
ensis A1 and A2 infections by targeting genomic regions
differing between A1 and A2 strains. The 2 real-time assays
were shown to be specific for either A1 or A2 and showed no
cross-reactivity to other Francisella or other bacterial species
tested. The sensitivity of both assays was determined to be
10 GEs, falling in line with the current real-time TaqMan
PCR assays used for identification of F. tularensis and F.
tularensis subsps. tularensis and holarctica (Kugeler et al.,
2006; Versage et al., 2003).
Identification of A1 and A2 infections by real-time PCR
was shown to directly correlate with results obtained by both
PFGE genotyping and conventional PCR (Petersen et al.,
2008) when specimens from sporadic cases and an outbreak
of tularemia were tested. PFGE and conventional PCR were
used successfully to describe the 2007 Utah outbreak as the
first documented tularemia outbreak involving both A1 and
A2 strains; however, limitations in detection were apparent
for both assays. PFGE was only useful for culture-positive
samples, and conventional PCR had a limit in sensitivity as
demonstrated by identification of the F. tularensis subsp.
tularensis infective clade for only 5 of the 15 PCR-positive,
culture-negative samples collected. Here, using the real-time
assays, the infecting clade was identified as either A1 or A2
within all 20 (culture-positive and PCR-positive, culture-
negative) human and rabbit specimens associated with the
outbreak. Thus, the real-time TaqMan PCR assays have the
advantage, in comparison with PFGE, MLVA, and conven-
tional PCR, of being not only rapid and gel free but also more
sensitive, allowing for identification of A1 and A2 in both
culture-positive and culture-negative samples. Both real-
time PCR assays show promise for identification of A1 and
A2 in primary specimens; however, because primary speci-
mens from only a single outbreak were evaluated in this
study, limitations to the data may exist.
Competitive inhibition testing of the A1 and A2 real-time
assays demonstrated the ability of these assays to detect both
A1 and A2 in a single sample. Currently, it is unknown
whether coinfections with A1 and A2 may occur in human,
animal, or vectors. To date, the only Francisella coinfection
studies documented have focused on F. novicida, with studies
finding that F. novicida can suppress the growth of F.
tularensis subsp. holarctica strain LVS by as much as 100-
fold using a rat model (Cowley et al., 1997). The co-
occurrence of A1 and A2 infections in a localized deer-fly–
Table 4
Identification of A1 and A2 infections in F. tularensis subsp. tularensis PCR-positive, culture-negative specimens
Sample
(CDC accession no.)
Source Specimen
type
F. tularensis
TaqMan PCR
F. tularensis subsp.
tularensis TaqMan PCR
A1 TaqMan Assaya
(+ or −/Ct value)
A2 TaqMan Assaya
(+ or −/Ct value)
Clade identified using
A1/A2 TaqMan assays
UT07-6575 Human Wound + + + / 36.98 − / − A1
UT07-6576 Human Wound + + − / − + / 36.83 A2
UT07-6577 Human Wound + + − / − + / 38.55 A2
UT07-6578 Human Wound + + + / 37.00 − / − A1
UT07-6579 Human Wound + + + / 38.74 − / − A1
UT07-6580 Human Lymph node + + − / − + / 33.05 A2
UT07-6581 Human Lymph node + + − / − + / 34.46 A2
UT07-5153 Rabbit Bone marrow + + + / 35.96 − / − A1
UT07-5158 Rabbit Bone marrow + + − / − + / 38.77 A2
UT07-5163 Rabbit Bone marrow + + − / − + / 35.02 A2
a A positive Ct value was logarithmic amplification detected within 41 amplification cycles; a negative Ct value was no logarithmic amplification detected
within 41 amplification cycles.
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associated outbreak of tularemia (Petersen et al., 2008) led us
to question whether coinfection with A1 and A2 may have
occurred during this outbreak. When the outbreak samples
were tested with A1 and A2 real-time PCR assays, no
evidence of coinfection was found. The implications of this
finding are unclear but could suggest that coinfection with A1
and A2 does not occur or that the deer-flies propagating the
outbreak were only singly infected with either A1 or A2.
Because no F. tularensis-positive deer-flies were recovered
(Petersen et al., 2008), it is not possible to distinguish
between these 2 possibilities.
Given that A1 infections are associated with a higher case
fatality rate than A2 infections (14% fatality rate for A1
infections as compared with 0% fatality rate for A2
infections) (Staples et al., 2006), the real-time assays
described here provide a new rapid and sensitive diagnostic
tool for clinical identification of A1 and A2 infections. In
addition, the 2 assays developed offer a rapid, sensitive, and
accessible tool for the research community to use for
classification of F. tularensis subsp. tularensis strains.
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